Completed PHASE4 INTERVENTIONAL 4-arm NCT03469271

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Resistance Training and 1,25 (OH)2D3 Administration to Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Sponsor: Andersen Foundation

Conditions Cancer

Interventions 1,25 (OH)2 D3 Inspiratory isometric resistance training Oral Placebo Sham Inspiratory Isometric Resistance Training Threshold Inspiratory Muscle Trainer (IMT)

Updated 9 times since 2018 Last updated: Sep 25, 2023 Started: May 25, 2018 Primary completion: May 21, 2020 Completion: May 21, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03469271, this PHASE4 trial focuses on Cancer and remains completed. Sponsored by Andersen Foundation, it has been updated 9 times since 2018, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Oct 2023 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Enrolling By Invitation → Completed

▶ Show 4 earlier versions

Feb 2020 — Dec 2020 [monthly]

Enrolling By Invitation PHASE4
Nov 2019 — Feb 2020 [monthly]

Enrolling By Invitation PHASE4
Sep 2018 — Nov 2019 [monthly]

Enrolling By Invitation PHASE4
Apr 2018 — Sep 2018 [monthly]

Enrolling By Invitation PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Andersen Foundation
Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States